Significant impact of new oral therapies against HCV on the waiting list for liver transplantation in Spain

J Hepatol. 2018 Oct;69(4):966-968. doi: 10.1016/j.jhep.2018.06.011. Epub 2018 Jul 7.

Authors

Marina Berenguer¹, Gloria de la Rosa Rodríguez², Beatriz Domínguez-Gil²

Affiliations

¹ Liver Transplantation and Hepatology Unit and Instituto de Investigación Sanitaria La Fe, University of Valencia, La Fe University Hospital, Valencia, Spain; CIBERehd (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Spain. Electronic address: marina.berenguer@uv.es.
² Organización Nacional de Trasplantes, Spain.

PMID: 30227917
DOI: 10.1016/j.jhep.2018.06.011

No abstract available

Keywords: Delisting; Direct-acting oral antivirals; Hepatitis C virus; Liver transplantation; Organ allocation; Waitlisting.

Publication types

Letter

MeSH terms

Administration, Oral
Antiviral Agents / administration & dosage
Antiviral Agents / therapeutic use*
Hepatitis C, Chronic / drug therapy*
Humans
Liver Transplantation*
Waiting Lists*

Substances

Antiviral Agents